Lejeune F - Search Results

1

S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile.

Millan MJ, Gobert A, Newman-Tancredi A, Lejeune F, Cussac D, Rivet JM, Audinot V, Adhumeau A, Brocco M, Nicolas JP, Boutin JA, Despaux N, Peglion JL. Millan MJ, et al. Among authors: lejeune f. J Pharmacol Exp Ther. 2000 Jan;292(1):38-53. J Pharmacol Exp Ther. 2000. PMID: 10604930

2

The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study.

Lejeune F, Gobert A, Millan MJ. Lejeune F, et al. Brain Res. 2002 May 10;935(1-2):134-9. doi: 10.1016/s0006-8993(02)02476-9. Brain Res. 2002. PMID: 12062484

3

The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats.

Lejeune F, Millan MJ. Lejeune F, et al. Eur J Pharmacol. 2003 Mar 19;464(2-3):127-33. doi: 10.1016/s0014-2999(03)01383-9. Eur J Pharmacol. 2003. PMID: 12620504

4

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.

Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. Millan MJ, et al. Among authors: lejeune f. J Pharmacol Exp Ther. 2004 Jun;309(3):903-20. doi: 10.1124/jpet.103.062398. Epub 2004 Feb 20. J Pharmacol Exp Ther. 2004. PMID: 14978194

5

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.

Millan MJ, Svenningsson P, Ashby CR Jr, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, Iob L, Veiga S, Gobert A. Millan MJ, et al. Among authors: lejeune f. J Pharmacol Exp Ther. 2008 Feb;324(2):600-11. doi: 10.1124/jpet.107.132563. Epub 2007 Nov 16. J Pharmacol Exp Ther. 2008. PMID: 18024787

6

S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.

Millan MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille-Girardon S, Verriele L, et al. Millan MJ, et al. Among authors: lejeune f. J Pharmacol Exp Ther. 1992 Aug;262(2):451-63. J Pharmacol Exp Ther. 1992. PMID: 1323650

7

Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.

Gobert A, Lejeune F, Rivet JM, Audinot V, Newman-Tancredi A, Millan MJ. Gobert A, et al. Among authors: lejeune f. J Pharmacol Exp Ther. 1995 Jun;273(3):1032-46. J Pharmacol Exp Ther. 1995. PMID: 7791073

8

Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.

Millan MJ, Rivet JM, Audinot V, Gobert A, Lejeune F, Brocco M, Newman-Tancredi A, Maurel-Remy S, Bervoets K. Millan MJ, et al. Among authors: lejeune f. J Pharmacol Exp Ther. 1995 Jun;273(3):1418-27. J Pharmacol Exp Ther. 1995. PMID: 7791116

9

Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors.

Lejeune F, Audinot V, Gobert A, Rivet JM, Spedding M, Millan MJ. Lejeune F, et al. Eur J Pharmacol. 1994 Jul 21;260(1):79-83. doi: 10.1016/0014-2999(94)90012-4. Eur J Pharmacol. 1994. PMID: 7957629

10

WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo.

Lejeune F, Rivet JM, Gobert A, Canton H, Millan MJ. Lejeune F, et al. Eur J Pharmacol. 1993 Aug 24;240(2-3):307-10. doi: 10.1016/0014-2999(93)90915-5. Eur J Pharmacol. 1993. PMID: 8243546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

548 results

Search Page